Requires MO HealthNet and health benefit plans providing for maternity benefits to cover a home blood pressure monitoring device and associated services for pregnant and postpartum women
SB 539 requires Missouri’s MO HealthNet program and certain private health benefit plans to cover a home blood pressure monitoring device and related services for pregnant and postpartum women. The bill defines the device as a mobile blood pressure monitor validated for clinical accuracy and calibration, and defines the covered services to include patient education and training, self-measurement readings, daily transmission of readings to a provider, provider review of the data, and treatment plan changes based on the readings.
The bill amends section 208.152, RSMo, by adding this new MO HealthNet benefit for eligible pregnant and postpartum women, and it creates a new section, 376.1960, requiring health benefit plans delivered, issued, continued, or renewed in Missouri on or after January 1, 2026, that provide maternity benefits to include the same coverage. In effect, the bill expands both Medicaid and private insurance coverage for remote blood pressure monitoring in the maternal health setting, which could affect providers, insurers, and MO HealthNet administration.
SB 539 would change Missouri law by adding a specific maternal-health coverage mandate to MO HealthNet and by imposing a parallel coverage requirement on certain private health benefit plans with maternity benefits. It would require coverage not only for the monitoring device itself but also for associated education, data transmission, and clinical review services, thereby creating a new reimbursable benefit category for pregnant and postpartum enrollees and insureds. The bill could increase utilization of remote monitoring services and may require insurers and the state Medicaid program to update benefit designs, claims processing, and reimbursement policies.
The available context shows no recorded committee testimony, votes, or formal opposition, so there is no documented debate history to gauge broad sentiment. Based on the bill’s caption and text, the measure appears to be framed as a maternal health and preventive care expansion, which typically suggests a supportive policy rationale centered on early detection and management of hypertension during pregnancy and after delivery. Because no votes or transcripts are provided, the overall legislative sentiment cannot be assessed beyond the bill’s apparent intent.
No specific points of contention are documented in the provided materials. Potential areas of debate, based on the bill text, could include the cost of adding a new mandated benefit, whether the coverage requirement should apply to all maternity plans or only certain plans, and how the state and insurers would implement reimbursement for device-related services. Another possible issue is the January 1, 2026 effective coverage date for private plans, which may raise questions about administrative readiness and compliance timelines.